Friday, March 26, 2021 / 12:30PM / NSE / Header Image Credit: GlaxoSmithKline Consumer Nigeria
This is to
notify the General Public and The Nigerian Stock Exchange, that the Board of
Directors' meeting of GlaxoSmithKline Consumer Nigeria Plc (the Company)
rescheduled to hold on Monday, 22nd March 2021 held as scheduled and the Board
of directors approved:
Audited Financial Statements of GlaxoSmithKline Consumer Nigeria Plc for the
financial year ended 31st December 2020.
Dividends to be proposed to Shareholders at the Annual General Meeting.
Public should take note that the closed period for dealing in the Company's
securities by the Directors, Managers or connected persons earlier announced
will terminate 24 hours after the release of the approved Audited Financial
Statements to the Market.
Visit GlaxoSmithKline Consumer Nigeria Plc IR Page in Proshare MARKETS
Graph - One Year Share Price Movement
Table: Q3 2020 Unaudited Results
Postpones Board Meeting to March 22 2021...
2. GLAXOSMITH declares N434m PAT
in Q3 2020 Unaudited Results SP N5.40K ...
3. GLAXOSMITH Appoints Mr. Oussama
Abbas As A Non-Executive Director Mr. Basel Niz...
4. GLAXOSMITH Notifies of
Resolutions Passed At Its 49th AGM...
5. GlaxoSmithKline Holds 49th AGM
Declares N657.7m Dividends...
6. GLAXOSMITH Notifies of Board
Meeting Date and Commencement of Closed Period
7. GLAXOSMITH To Hold 49th AGM on
July 23, 2020; Lists Proxies
8. GLAXOSMITH declares N113m PAT
in Q1 2020 Result; (SP:N7.50K)
9. GLAXOSMITH declares N917m PAT
in 2019 Audited Results Proposes N0.55K Final Div...